RIZZOTTO, Lara
 Distribuzione geografica
Continente #
NA - Nord America 2.494
EU - Europa 696
AS - Asia 550
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.742
Nazione #
US - Stati Uniti d'America 2.487
CN - Cina 266
DE - Germania 183
SG - Singapore 157
UA - Ucraina 144
IT - Italia 117
TR - Turchia 109
GB - Regno Unito 70
FI - Finlandia 52
SE - Svezia 46
BE - Belgio 19
FR - Francia 17
RU - Federazione Russa 17
CZ - Repubblica Ceca 15
CA - Canada 7
RO - Romania 6
ID - Indonesia 5
NL - Olanda 4
LT - Lituania 3
IN - India 2
KR - Corea 2
TW - Taiwan 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
PT - Portogallo 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.742
Città #
Woodbridge 358
Chandler 253
Fairfield 252
Jacksonville 169
Santa Clara 155
Ann Arbor 150
Houston 144
Singapore 131
Seattle 110
Ashburn 108
Wilmington 100
Cambridge 97
Beijing 69
Izmir 62
Ferrara 47
New York 46
Nanjing 42
Princeton 38
Shanghai 36
Boardman 33
Milan 31
San Diego 23
Bremen 22
Brussels 19
Dearborn 17
Helsinki 17
Los Angeles 17
Shenyang 17
Nanchang 16
Addison 15
Brno 15
Munich 14
Changsha 12
Frankfurt am Main 11
Guangzhou 9
Jiaxing 9
Tianjin 9
Jinan 8
Auburn Hills 7
Mountain View 7
Toronto 7
Zhengzhou 7
London 6
Norwalk 6
Orange 6
Falls Church 5
Jakarta 5
San Jose 5
Washington 5
Bologna 4
Redwood City 4
Amsterdam 3
Augusta 3
Des Moines 3
Hebei 3
Hefei 3
Paris 3
San Mateo 3
Dong Ket 2
Espoo 2
Falkenstein 2
Fuzhou 2
Monmouth Junction 2
Redmond 2
San Francisco 2
Taipei 2
Tappahannock 2
Verona 2
Ardabil 1
Berlin 1
Changchun 1
Chengdu 1
Chicago 1
Copenhagen 1
Crotone 1
Hangzhou 1
Hounslow 1
Johor Bahru 1
Kunming 1
Lanzhou 1
Leawood 1
Lisbon 1
Manchester 1
Melbourne 1
Mercer Island 1
Miami 1
New Bedfont 1
Ningbo 1
North Bergen 1
Philadelphia 1
Quanzhou 1
Rockville 1
Seoul 1
Sofia 1
Taizhou 1
Velp 1
Venezia 1
Wuhan 1
Xianyang 1
Yellow Springs 1
Totale 2.828
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 166
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 146
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 139
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 138
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 133
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 130
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia. 128
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 128
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 128
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 123
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 117
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 112
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 111
Rescue of coagulation factor VII function by the U1+5A snRNA 111
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency 106
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 104
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 101
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 100
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 99
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 99
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 97
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 96
null 94
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 84
null 82
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 82
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 79
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 76
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 74
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 74
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 65
Non-conventional therapeutic strategies for inherited disorders of hemostasis 64
null 64
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 61
Erratum to: Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical-prognostic and biologic significance (Cancer (2010) 116, (1926-37)) 45
null 42
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 40
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 36
“Compensatory” aberrant splicing supports residual expression levels in severe coagulation factor VII deficiency 34
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 31
Extended lifespan of normal human B lymphocytes experimentally infected by SV40 or transfected by SV40 large T antigen expression vector 29
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 19
Totale 3.787
Categoria #
all - tutte 17.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.405


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020378 0 0 0 0 0 83 55 66 51 80 30 13
2020/2021480 37 28 25 62 11 58 22 56 12 53 81 35
2021/2022442 38 55 27 10 29 18 16 21 9 34 50 135
2022/2023524 49 52 8 80 96 68 28 44 66 2 22 9
2023/2024233 25 26 9 3 12 50 9 12 8 6 3 70
2024/2025400 14 24 73 45 137 107 0 0 0 0 0 0
Totale 3.787